Aberrant Excitatory–Inhibitory Synaptic Mechanisms in Entorhinal Cortex Microcircuits During the Pathogenesis of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Synaptic dysfunction is widely proposed as an initial insult leading to the neurodegeneration observed in Alzheimer's disease (AD). We hypothesize that the initial insult originates in the lateral entorhinal cortex (LEC) due to deficits in key interneuronal functions and synaptic signaling mechanisms, in particular, Wnt (Wingless/integrated). To investigate this hypothesis, we utilized the first knock-in mouse model of AD (AppNL-F/NL-F), expressing a mutant form of human amyloid-β (Aβ) precursor protein. This model shows an age-dependent accumulation of Aβ, neuroinflammation, and neurodegeneration. Prior to the typical AD pathology, we showed a decrease in canonical Wnt signaling activity first affecting the LEC in combination with synaptic hyperexcitation and severely disrupted excitatory-inhibitory inputs onto principal cells. This synaptic imbalance was consistent with a reduction in the number of parvalbumin-containing (PV) interneurons, and a reduction in the somatic inhibitory axon terminals in the LEC compared with other cortical regions. However, targeting GABAA receptors on PV cells using allosteric modulators, diazepam, zolpidem, or a nonbenzodiazepine, L-838,417 (modulator of α2/3 subunit-containing GABAA receptors), restored the excitatory-inhibitory imbalance observed at principal cells in the LEC. These data support our hypothesis, providing a rationale for targeting the synaptic imbalance in the LEC for early stage therapeutic intervention to prevent neurodegeneration in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, under pathological conditions, microglia can also affect the balance between excitatory and inhibitory synapses by phagocytosing synapses 223 and activating inflammatory factors in microglia. 224”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [223]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · cited 1×
“As GABAergic cells are highly diverse in their properties and synapse on specific postsynaptic subcellular domains, (Maccaferri and Lacaille 2003; Markram et al. 2004; Ascoli et al. 2008; Klausberger and Somogyi 2008; Pelkey et al. 2017) even subtle disruption in interneuron behavior could unequivocally impact glutama…”
BackgroundBuckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · cited 1×
“This is evidenced by imaging studies from preclinical and symptomatic AD patients during memory tasks (Buckner et al. 2005; O’Brien et al. 2010; Bero et al. 2012).”
MethodNeuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050 · cited 1×
“As GABAergic cells are highly diverse in their properties and synapse on specific postsynaptic subcellular domains, (Maccaferri and Lacaille 2003; Markram et al. 2004; Ascoli et al. 2008; Klausberger and Somogyi 2008; Pelkey et al. 2017) even subtle disruption in interneuron behavior could unequivocally impact glutama…”
BackgroundAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“This abnormal hyperactivity is thought to be detrimental by causing Aβ release, spreading and accumulating during AD progression (Kamenetz et al. 2003; Busche et al. 2008; Cirrito et al. 2008; Yamamoto et al. 2015).”
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592 · cited 1×
“All procedures were approved by both internal and external UCL ethics committees, and in accordance with the ARRIVE guidelines for reporting experiments involving animals (McGrath et al. 2010).”
MethodPetilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex
The Petilla Interneuron Nomenclature Group (PING) (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2402 · Cited by 1,491 · cited 2×
“initial segments (Kawaguchi and Kubota 1993; Klausberger et al. 2005; Ascoli et al. 2008), accounts for ~40% of cortical GABAergic neurons (Rudy et al.”
BackgroundAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424 · cited 2×
“This accumulation of Aβ protein plaques is known to be initiated in the LEC and layer 2/3 of the neocortex border ((Braak and Braak 1991; Holtzman et al. 2011), which is consistent with our study showing an increase of Aβ protein plaques in the LEC of App F/NL-F mice by, 12.”
BackgroundResultThree groups of interneurons account for nearly 100% of neocortical GABAergic neurons
Rudy, B., Fishell, G., Lee, S., & Hjerling‐Leffler, J. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20853 · Cited by 1,420 · cited 1×
“2008), accounts for ~40% of cortical GABAergic neurons (Rudy et al. 2011).”
BackgroundSingle App knock-in mouse models of Alzheimer’s disease
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., & Saido, T. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3697 · Cited by 1,366 · cited 6×
“There was a higher level of Aβ42/Aβ40 associated in the AppNL-F/NL-F mouse model at 10–18 months as opposed to their age-matched wild-type control mice (Fig.”
BackgroundMethodInfluentialSelf-citationGamma frequency entrainment attenuates amyloid load and modifies microglia
Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328 · cited 2×
“This GABAA receptors, combination results in these cells showing activation in the γ frequency range in AD mice thereby reducing the spread of Aβ 1–40 and Aβ 1–42 isoforms before the onset of plaque formation or cognitive decline (Iaccarino et al. 2016).”
BackgroundVerret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216 · cited 2×
“…et al. 2004; Ascoli et al. 2008; Klausberger and Somogyi 2008; Pelkey et al. 2017) even subtle disruption in interneuron behavior could unequivocally impact glutamatergic release, resulting in aberrant cortical excitation (Marin 2012; Verret et al. 2012; Palop and Mucke 2016; Khan et al. 2018).”
BackgroundInterneuron dysfunction in psychiatric disorders
Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190 · cited 2×
“…et al. 2004; Ascoli et al. 2008; Klausberger and Somogyi 2008; Pelkey et al. 2017) even subtle disruption in interneuron behavior could unequivocally impact glutamatergic release, resulting in aberrant cortical excitation (Marin 2012; Verret et al. 2012; Palop and Mucke 2016; Khan et al. 2018).”
BackgroundClusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease
Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125 · cited 4×
“Others have also shown that AD associated insults to cortical regions can be restored or intercepted with either pharmacological agents (Busche et al. 2008; Busche and Konnerth 2016), or by optogenetic experiments inducing specific oscillatory states such as gamma (Iaccarino et al.”
BackgroundResultInfluentialNetwork abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022 · cited 1×
“2017) even subtle disruption in interneuron behavior could unequivocally impact glutamatergic release, resulting in aberrant cortical excitation (Marin 2012; Verret et al. 2012; Palop and Mucke 2016; Khan et al. 2018).”
BackgroundMcKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944 · cited 2×
“2007), which are subtypes of GABAA receptors shown to be associated with postsynaptic domains targeted by PV interneurons (Ali and Thomson 2008), and with little sedative or amnestic effects that are associated with α1 subtypes (McKernan et al. 2000).”
BackgroundReduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
Bakker, A., Krauss, G. L., Albert, M. S., Speck, C. L., Jones, L. R., Stark, C. E., Yassa, M. A., Bassett, S. S., Shelton, A. L., & Gallagher, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.023 · Cited by 908 · cited 1×
“This idea is further supported by studies reporting that a low dose of the antiepileptic drug levetiracetam can reduce hippocampal hyperactivity in humans and improve amnestic mild cognitive impairment (Bakker et al. 2012).”
ResultHippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889 · cited 1×
“As GABAergic cells are highly diverse in their properties and synapse on specific postsynaptic subcellular domains, (Maccaferri and Lacaille 2003; Markram et al. 2004; Ascoli et al. 2008; Klausberger and Somogyi 2008; Pelkey et al. 2017) even subtle disruption in interneuron behavior could unequivocally impact glutama…”
BackgroundAPP mouse models for Alzheimer’s disease preclinical studies.
Sasaguri, H., Nilsson, P., Hashimoto, S., Nagata, K., Saito, T., De Strooper, B., Hardy, J., Vassar, R., Winblad, B., & Saido, T. C. (2017) · The EMBO Journal · doi:10.15252/embj.201797397 · Cited by 793 · cited 2×
“…mouse model (AppNL-F/NL-F), which faithfully recapitulates disease progression in AD patients as shown by molecular studies (Saito et al. 2014; Sasaguri et al. 2017), we explored progressive changes in synaptic mechanisms underlying AD pathology in the LEC with the following 3 key findings:…”
BackgroundSelf-citationA network dysfunction perspective on neurodegenerative diseases
Palop, J. J., Chin, J., & Mucke, L. (2006) · Nature · doi:10.1038/nature05289 · Cited by 692 · cited 1×
“aptic loss leading to neurodegeneration and progressive cognitive deficits (Palop et al. 2006).”
BackgroundEndocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635 · cited 1×
“This abnormal hyperactivity is thought to be detrimental by causing Aβ release, spreading and accumulating during AD progression (Kamenetz et al. 2003; Busche et al. 2008; Cirrito et al. 2008; Yamamoto et al. 2015).”
BackgroundEmerging roles of Wnts in the adult nervous system
Inestrosa, N. C., & Arenas, E. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2755 · Cited by 612 · cited 2×
“…Wnt3a ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APPNL-F/NL-F animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo et al. 2016; Jin et al. 2017, Huang et al.…”
BackgroundDemonstration of amyloid deposits and neurofibrillary changes in whole brain sections
Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598 · cited 2×
“This accumulation of Aβ protein plaques is known to be initiated in the LEC and layer 2/3 of the neocortex border ((Braak and Braak 1991; Holtzman et al. 2011), which is consistent with our study showing an increase of Aβ protein plaques in the LEC of App F/NL-F mice by, 12.”
ResultInfluentialKhan, U. A., Liu, L., Provenzano, F. A., Berman, D. E., Profaci, C. P., Sloan, R., Mayeux, R., Duff, K. E., & Small, S. A. (2014) · Nature Neuroscience · doi:10.1038/nn.3606 · Cited by 561 · cited 2×
“The observed aberrant function of the LEC is consistent with preclinical human fMRI studies that have also shown pathology to be initiated in the LEC (Khan et al. 2014).”
BackgroundResultKawaguchi, Y., & Kubota, Y. (1993) · Journal of Neurophysiology · doi:10.1152/jn.1993.70.1.387 · Cited by 558 · cited 1×
“initial segments (Kawaguchi and Kubota 1993; Klausberger et al. 2005; Ascoli et al. 2008), accounts for ~40% of cortical GABAergic neurons (Rudy et al.”
BackgroundOlabarria, M., Noristani, H. N., Verkhratsky, A., & Rodríguez, J. J. (2010) · Glia · doi:10.1002/glia.20967 · Cited by 499 · cited 1×
“cells, which themselves have been shown to be altered morphologically (Olabarria et al. 2010; Rodriguez et al. 2010).”
BackgroundFast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin
Kawaguchi, Y., Katsumaru, H., Kosaka, T., Heizmann, C. W., & Hama, K. (1987) · Brain Research · doi:10.1016/0006-8993(87)90921-8 · Cited by 485
Klausberger, T., Marton, L. F., O'Neill, J., Huck, J. H. J., Dalezios, Y., Fuentealba, P., Suen, W. Y., Papp, E., Kaneko, T., Watanabe, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3269-05.2005 · Cited by 469 · cited 1×
“initial segments (Kawaguchi and Kubota 1993; Klausberger et al. 2005; Ascoli et al. 2008), accounts for ~40% of cortical GABAergic neurons (Rudy et al.”
BackgroundImpairments of neural circuit function in Alzheimer's disease
Busche, M. A., & Konnerth, A. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0429 · Cited by 360 · cited 1×
“Others have also shown that AD associated insults to cortical regions can be restored or intercepted with either pharmacological agents (Busche et al. 2008; Busche and Konnerth 2016), or by optogenetic experiments inducing specific oscillatory states such as gamma (Iaccarino et al.”
BackgroundWnt signaling in the nervous system and in Alzheimer's disease
Inestrosa, N. C., & Varela-Nallar, L. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt051 · Cited by 324
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline
O'Brien, J. L., O'Keefe, K. M., LaViolette, P. S., DeLuca, A. N., Blacker, D., Dickerson, B. C., & Sperling, R. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e3966e · Cited by 299 · cited 1×
“This is evidenced by imaging studies from preclinical and symptomatic AD patients during memory tasks (Buckner et al. 2005; O’Brien et al. 2010; Bero et al. 2012).”
MethodToledo, E. M., & Inestrosa, N. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.72 · Cited by 293 · cited 2×
“…such as Wnt3a ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APPNL-F/NL-F animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo et al. 2016; Jin et al. 2017,…”
BackgroundCognitive deficits in single App knock-in mouse models
Masuda, A., Kobayashi, Y., Kogo, N., Saito, T., Saido, T. C., & Itohara, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.07.001 · Cited by 248 · cited 2×
“These cellular properties observed in vitro correlate with the behavioral abnormalities of this AD mouse model detected from 10 months onwards (Masuda et al. 2016).”
BackgroundSelf-citationChronic Optogenetic Activation Augments Aβ Pathology in a Mouse Model of Alzheimer Disease
Yamamoto, K., Tanei, Z.-I., Hashimoto, T., Wakabayashi, T., Okuno, H., Naka, Y., Yizhar, O., Fenno, L. E., Fukayama, M., Bito, H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.017 · Cited by 231 · cited 2×
“This abnormal hyperactivity is thought to be detrimental by causing Aβ release, spreading and accumulating during AD progression (Kamenetz et al. 2003; Busche et al. 2008; Cirrito et al. 2008; Yamamoto et al. 2015).”
BackgroundLiu, C.-C., Tsai, C.-W., Deak, F., Rogers, J., Penuliar, M., Sung, Y. M., Maher, J. N., Fu, Y., Li, X., Xu, H., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.048 · Cited by 222 · cited 1×
“For example, knockout of the specific canonical Wnt signaling co-receptor Lrp6 leads to age related structural and functional synaptic changes in wild type mice and accelerates pathogenic changes in AD mouse models (Liu et al. 2014).”
BackgroundWnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons
Alvarez, A. R., Godoy, J. A., Mullendorff, K., Olivares, G. H., Bronfman, M., & Inestrosa, N. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.028 · Cited by 213 · cited 1×
“Vice versa treatment with stimulators of canonical Wnt signaling such as Wnt3a ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APP animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo e…”
BackgroundDistribution of CaMKIIα expression in the brain in vivo, studied by CaMKIIα-GFP mice
Wang, X., Zhang, C., Szábo, G., & Sun, Q.-Q. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.042 · Cited by 206 · cited 1×
“Furthermore, to investigate whether principal pyramidal cells showed neurodegeneration in the AppNL-F/NL-F mouse model, we performed immunohistochemistry using antibody against CaMKII-α which is expressed in principal cells (Wang et al. 2013), and costained the tissue with DAPI (nuclei staining).”
MethodThe role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease
Inestrosa, N. C., & Toledo, E. M. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-9 · Cited by 206
Maccaferri, G., & Lacaille, J.-C. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.002 · Cited by 204
The secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss
Purro, S. A., Dickins, E. M., & Salinas, P. C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4562-11.2012 · Cited by 195 · cited 1×
“…expression during development might cause subtle neuronal changes, resulting in an increased vulnerability to neurodegenerative insults that becomes evident during aging (Zhou et al. 2012; Purro et al. 2012, 2014; Tapia-Rojas et al. 2016; Elliott et al. 2018; Tapia-Rojas and Inestrosa 2018a,b).”
BackgroundGABAAreceptors in aging and Alzheimer’s disease
Rissman, R. A., De Blas, A. L., & Armstrong, D. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04832.x · Cited by 192 · cited 1×
“…patients could be perceived as paradoxical, since several reports have shown that the inhibitory GABA receptor (GABAA) family is actually preserved in human brains of AD patients (Howell et al. 2000; Rissman et al. 2007), although the GABAA receptors subtype that survives remains largely unclear.”
BackgroundBidirectional Relationship between Functional Connectivity and Amyloid-β Deposition in Mouse Brain
Bero, A. W., Bauer, A. Q., Stewart, F. R., White, B. R., Cirrito, J. R., Raichle, M. E., Culver, J. P., & Holtzman, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5845-11.2012 · Cited by 181 · cited 1×
“This is evidenced by imaging studies from preclinical and symptomatic AD patients during memory tasks (Buckner et al. 2005; O’Brien et al. 2010; Bero et al. 2012).”
MethodLithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice
Fiorentini, A., Rosi, M. C., Grossi, C., Luccarini, I., & Casamenti, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014382 · Cited by 175 · cited 1×
“Vice versa treatment with stimulators of canonical Wnt signaling such as Wnt3a ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APP animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo e…”
BackgroundWnts in adult brain: from synaptic plasticity to cognitive deficiencies
Oliva, C. A., Vargas, J. Y., & Inestrosa, N. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00224 · Cited by 162
Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders
Zhang, W., Zhang, L., Liang, B., Schroeder, D., Zhang, Z.-W., Cox, G. A., Li, Y., & Lin, D.-T. (2016) · Nature Neuroscience · doi:10.1038/nn.4257 · Cited by 159 · cited 1×
“Similarly, others have also reported hypoactivity of PV cell membrane properties (Zhang et al. 2016).”
BackgroundRegulation of NMDA-Receptor Synaptic Transmission by Wnt Signaling
Cerpa, W., Gambrill, A., Inestrosa, N. C., & Barria, A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6311-10.2011 · Cited by 148
Physiology of neuronal–glial networking
Verkhratsky, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.002 · Cited by 148 · cited 2×
“Astrocytes regulate the microenvironment by providing K+ ion homeostasis for excitable membranes, and their reduced function could lead to an accumulation of extracellular K+ released from neurons (Verkhratsky 2010), resulting in a more depolarized membrane potential, rendering cells more excitable.”
BackgroundReversal of Synapse Degeneration by Restoring Wnt Signaling in the Adult Hippocampus
Marzo, A., Galli, S., Lopes, D., McLeod, F., Podpolny, M., Segovia-Roldan, M., Ciani, L., Purro, S., Cacucci, F., Gibb, A., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.024 · Cited by 139 · cited 1×
“Vice versa treatment with stimulators of canonical Wnt signaling such as Wnt3a ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APP animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo e…”
BackgroundLoss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer’s disease.
Inestrosa, N., & Tapia-Rojas, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238606 · Cited by 137
Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques
Garcia-Marin, V. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.028.2009 · Cited by 136 · cited 1×
“GABA terminals are found adjacent to Aβ plaques suggesting that Aβ plaque accumulation directly initiates cellular dysfunction in patients affected by AD (Garcia-Marin et al. 2009).”
BackgroundYang, X., Yao, C., Tian, T., Li, X., Yan, H., Wu, J., Li, H., Pei, L., Liu, D., Tian, Q., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.151 · Cited by 136
GABAA Receptor Subtype-Selective Modulators. I. α2/α3-Selective Agonists as Non-Sedating Anxiolytics
R. Atack, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795371350 · Cited by 132 · cited 1×
“…et al. 2018) thus, we further investigated specific GABAA receptor allosteric modulators including zolpidem (1 μM), a modulator of α1-containing GABAA receptors, and L-838,417 (0.5 μM), a selective modulator of α2- and α3- containing GABAARs, classed as a nonbenzodiazepine anxiolytic (Atack 2011).”
BackgroundInfluentialAli, A. B., & Thomson, A. M. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm160 · Cited by 129
Self-citationWnts in action: from synapse formation to synaptic maintenance
Dickins, E. M., & Salinas, P. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00162 · Cited by 125
Wnt-5aoccludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons
Cerpa, W., Farías, G. G., Godoy, J. A., Fuenzalida, M., Bonansco, C., & Inestrosa, N. C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-3 · Cited by 119 · cited 1×
“…of Wnt signaling are crucial for synaptic maintenance that includes presynaptic neurotransmitter release, glutamate receptor trafficking and postsynaptic receptor clustering by postsynaptic density protein 95 (PSD-95) (Inestrosa and Arenas 2010; Cerpa et al. 2010, 2011; Park and Shen 2012).”
BackgroundRodríguez, J. J., Witton, J., Olabarria, M., Noristani, H. N., & Verkhratsky, A. (2010) · Cell Death & Disease · doi:10.1038/cddis.2009.2 · Cited by 114 · cited 1×
“cells, which themselves have been shown to be altered morphologically (Olabarria et al. 2010; Rodriguez et al. 2010).”
BackgroundDysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases
Purro, S. A., Galli, S., & Salinas, P. C. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt049 · Cited by 114
Parr, C., Mirzaei, N., Christian, M., & Sastre, M. (2015) · The FASEB Journal · doi:10.1096/fj.14-253211 · Cited by 113 · cited 1×
“…ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APPNL-F/NL-F animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo et al. 2016; Jin et al. 2017, Huang et al. 2018).”
BackgroundWNTs in synapse formation and neuronal circuitry
Park, M., & Shen, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.145 · Cited by 110
A role for APP in Wnt signalling links synapse loss with β-amyloid production
Elliott, C., Rojo, A. I., Ribe, E., Broadstock, M., Xia, W., Morin, P., Semenov, M., Baillie, G., Cuadrado, A., Al-Shawi, R., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0231-6 · Cited by 107 · cited 1×
“…expression during development might cause subtle neuronal changes, resulting in an increased vulnerability to neurodegenerative insults that becomes evident during aging (Zhou et al. 2012; Purro et al. 2012, 2014; Tapia-Rojas et al. 2016; Elliott et al. 2018; Tapia-Rojas and Inestrosa 2018a,b).”
BackgroundWnt signaling: Role in LTP, neural networks and memory
Oliva, C. A., Vargas, J., & Inestrosa, N. C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.006 · Cited by 96
Jin, N., Zhu, H., Liang, X., Huang, W., Xie, Q., Xiao, P., Ni, J., & Liu, Q. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.006 · Cited by 89 · cited 2×
“…ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APPNL-F/NL-F animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo et al. 2016; Jin et al. 2017, Huang et al. 2018).”
BackgroundResultApplication of modified Sholl analysis to neuronal dendritic arborization of the cat spinal cord
Ristanović, D., Milošević, N. T., & Štulić, V. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.05.030 · Cited by 85 · cited 1×
“represented morphological alterations (Ristanovic et al. 2006).”
Tapia‐Rojas, C., & Inestrosa, N. C. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14278 · Cited by 85
Khan, A. A., Shekh‐Ahmad, T., Khalil, A., Walker, M. C., & Ali, A. B. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14202 · Cited by 84 · cited 3×
“4A,B), which was very similar to previous observations made in epileptic tissue (Khan et al. 2018).”
BackgroundMethodResultSelf-citationTapia‐Rojas, C., Burgos, P. V., & Inestrosa, N. C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13873 · Cited by 76 · cited 1×
“…expression during development might cause subtle neuronal changes, resulting in an increased vulnerability to neurodegenerative insults that becomes evident during aging (Zhou et al. 2012; Purro et al. 2012, 2014; Tapia-Rojas et al. 2016; Elliott et al. 2018; Tapia-Rojas and Inestrosa 2018a,b).”
BackgroundImpaired In Vivo Gamma Oscillations in the Medial Entorhinal Cortex of Knock-in Alzheimer Model
Nakazono, T., Lam, T. N., Patel, A. Y., Kitazawa, M., Saito, T., Saido, T. C., & Igarashi, K. M. (2017) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2017.00048 · Cited by 76 · cited 1×
“2008; Busche and Konnerth 2016), or by optogenetic experiments inducing specific oscillatory states such as gamma (Iaccarino et al. 2016; Nakazono et al. 2017) or theta oscillations (Yang et al.”
BackgroundSelf-citationNicholson, M. W., Sweeney, A., Pekle, E., Alam, S., Ali, A. B., Duchen, M. R., & Jovanovic, J. N. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0100-y · Cited by 76 · cited 1×
“However, diazepam as a potential therapeutic target for AD is controversial (Nicholson et al. 2018) thus, we further investigated specific GABAA receptor allosteric modulators including zolpidem (1 μM), a modulator of α1-containing GABAA receptors, and L-838,417 (0.5 μM), a selective modulator of…”
BackgroundInfluentialSelf-citationThe regulation and deregulation of Wnt signaling by PARK genes in health and disease
Berwick, D. C., & Harvey, K. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt037 · Cited by 75
Self-citationAltered Synapse Stability in the Early Stages of Tauopathy
Jackson, J. S., Witton, J., Johnson, J. D., Ahmed, Z., Ward, M., Randall, A. D., Hutton, M. L., Isaac, J. T., O’Neill, M. J., & Ashby, M. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.013 · Cited by 73 · cited 1×
“, before the signs of neuroinflammation and Aβ plaque formation in the LEC, which is also corroborated by recent study using rTg4510 transgenic mouse line studying tauopthay (Jackson et al. 2017).”
ResultHowell, O. W., Atack, J. R., Dewar, D., McKernan, R. M., & Sur, C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00163-9 · Cited by 72
Huang, M., Liang, Y., Chen, H., Xu, B., Chai, C., & Xing, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00164 · Cited by 64 · cited 2×
“…ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APPNL-F/NL-F animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo et al. 2016; Jin et al. 2017, Huang et al. 2018).”
BackgroundResultThe APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth
Zhou, F., Gong, K., Song, B., Ma, T., van Laar, T., Gong, Y., & Zhang, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.011 · Cited by 62
Dengler-Crish, C. M., Ball, H. C., Lin, L., Novak, K. M., & Cooper, L. N. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.021 · Cited by 58 · cited 1×
“…canonical Wnt signaling has previously been suggested to play a role in AD pathogenesis in patients and has also been observed in other AD animal models (Inestrosa and Varela-Nallar 2014; Jin et al. 2017; Dengler-Crish et al. 2018; Huang et al. 2018; Tapia-Rojas and Inestrosa 2018a, b).”
ResultRegulating Wnt signaling: a strategy to prevent neurodegeneration and induce regeneration
Harvey, K., & Marchetti, B. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju002 · Cited by 33 · cited 2×
“Vice versa treatment with stimulators of canonical Wnt signaling such as Wnt3a ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APP animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo e…”
BackgroundSelf-citationKrüppel-like Factor 8 Ameliorates Alzheimer's Disease by Activating β-Catenin
Yi, R., Chen, B., Zhao, J., Zhan, X., Zhang, L., Liu, X.-M., & Dong, Q. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0131-4 · Cited by 25 · cited 1×
“Vice versa treatment with stimulators of canonical Wnt signaling such as Wnt3a ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APP animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo e…”
BackgroundMathiasen, L., Rodgers, R. J., & Mirza, N. R. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32814fcdd4 · Cited by 24 · cited 1×
“Zolpidem is specifically known to target α1 containing GABAA receptors, while L-838,417 has been shown primarily to activate α2 and α3 subunit-containing GABAA receptors, (McKernan et al. 2000; Mathiasen et al. 2007; Ujfalussy et al. 2007), which are subtypes of GABAA receptors shown to be associated with postsynaptic…”
BackgroundOliva, C. A., & Inestrosa, N. C. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.027 · Cited by 24
Regulating Wnt signaling: a strategy to prevent neurodegeneration and induce regeneration
Guest, Kirsten, Harvey, et al. (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 20
Ujfalussy, B. B., Kiss, T., Orbán, G., Hoffmann, W. E., Érdi, P., & Hajós, M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.022 · Cited by 17 · cited 2×
“…while L-838,417 has been shown primarily to activate α2 and α3 subunit-containing GABAA receptors, (McKernan et al. 2000; Mathiasen et al. 2007; Ujfalussy et al. 2007), which are subtypes of GABAA receptors shown to be associated with postsynaptic domains targeted by PV interneurons (Ali…”
BackgroundWnt signaling regulates experience-dependent synaptic plasticity in the adult nervous system
Jensen, M., Brockie, P. J., & Maricq, A. V. (2012) · Cell Cycle · doi:10.4161/cc.21138 · Cited by 14
Yang, X., Yao, C., Tian, T., Li, X., Yan, H., Wu, J., Li, H., Pei, L., Liu, D., Tian, Q., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2018.1 · Cited by 6
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“However, under pathological conditions, microglia can also affect the balance between excitatory and inhibitory synapses by phagocytosing synapses 223 and activating in fl ammatory factors in microglia.”
BackgroundLi, S., & Selkoe, D. J. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15007 · Cited by 263
“…have suggested that the loss of balance of excitatory versus inhibitory neurotransmitter systems may underline early cognitive deficits and occasional epileptiform activity in AD (Goutagny et al., 2013; Petrache et al., 2019; Stoiljkovic, Kelley, Horvath, & Hajos, 2018; Vossel et al., 2016).”
Bi, D., Wen, L., Wu, Z., & Shen, Y. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12088 · Cited by 232
Hijazi, S., Heistek, T. S., Scheltens, P., Neumann, U., Shimshek, D. R., Mansvelder, H. D., Smit, A. B., & van Kesteren, R. E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0483-4 · Cited by 216
“of AD at this age [24, 27, 45, 57, 58], is prevented by the treatment, and the hyperexcitability of pyramidal neurons, which is also reported in AD mice [3, 12, 19, 47–49, 59], is completely restored.”
BackgroundMeftah, S., & Gan, J. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1129036 · Cited by 205
“Interestingly, in the entorhinal cortex in the APPNL−F mouse model, there were synaptic deficits from an early age (1 month +) (Petrache et al., 2019).”
Background
Metadata
- Authors
- Petrache, A. L., Rajulawalla, A., Shi, A., Wetzel, A., Saito, T., Saido, T. C., Harvey, K., & Ali, A. B.
- Affiliations
- UCL School of Pharmacy (GB)
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Ali, Afia B
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-02-15
- Volume
- 29
- Issue
- 4
- Pages
- 1834-1850
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- PMC
- PMC6418384
- OpenAlex
- W2913978847
- Cited by
- 124
- References
- 81
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 29 · 2023: 19 · 2022: 16 · 2021: 16 · 2020: 18 · 2019: 4
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cerebral Cortex (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- New Investigators award (GO501263)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, lateral entorhinal cortex, excitatory-inhibitory imbalance, Wnt signaling, parvalbumin interneurons, GABAA receptor, amyloid precursor protein, neurodegeneration, diazepam, zolpidem, neuroinflammation
- MeSH terms
- Alzheimer Disease, Animals, Disease Models, Animal, Humans, Inflammation, Male, Mice, Inbred C57BL, Mice, Transgenic, Neural Inhibition, Neurons, Receptors, GABA-A, Synapses, Amyloid beta-Protein Precursor, Entorhinal Cortex, Tissue Culture Techniques, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.